Company
Brisbane, QLD
Every investor coverage indicates participated in a round Translational Research Institute raised.
Companies Translational Research Institute acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Scott Bell | CEO | @AuManufacturing |
Stories naming Translational Research Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.
Roundup of Australian manufacturing news: ARM Hub's anniversary, DroneShield orders, EMVision's milestone grant, SciDev results, a SEA Electric hire, ATSE's policy submission, and spaceport funding for Koonibba.
A cleanroom facility for medical technology startups has opened at a Brisbane research institute, backed by a growth centre grant, matching institute funding and in-kind help from a resident vaccine-platform developer.